Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

[A case of myocardiac metastasis of clear cell renal carcinoma successfully treated with sunitinib].

Tatenuma T, Yao M, Sakata R, Sano F, Makiyama K, Nakaigawa N, Nakayama T, Inayama Y, Kubota Y.

Hinyokika Kiyo. 2013 Feb;59(2):97-101. Japanese.

2.

[PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB].

Namura K, Otake S, Sawada T, Fujikawa A, Ota J, Moriyama M.

Nihon Hinyokika Gakkai Zasshi. 2015 Jan;106(1):30-4. Japanese.

PMID:
26399128
3.

[Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma].

Morizawa Y, Momose H, Toyoshima Y, Takada S, Fujimoto K, Oyama N.

Hinyokika Kiyo. 2013 Dec;59(12):791-3. Japanese.

4.

[Advanced sarcomatoid renal cell carcinoma effectively treated with sunitinib: report of a case].

Tsuchiyama K, Ito H, Ishida H, Itoh H, Yokoyama O.

Hinyokika Kiyo. 2011 Nov;57(11):615-8. Japanese.

5.

[A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].

Komeya M, Matsumoto T, Fujinami K, Senga Y, Asakura T, Goto A.

Hinyokika Kiyo. 2010 Sep;56(9):499-503. Review. Japanese.

6.

Multifocal brain metastases in clear cell renal cell carcinoma with complete response to sunitinib.

Zeng H, Li X, Yao J, Zhu Y, Liu J, Yang Y, Qiang W.

Urol Int. 2009;83(4):482-5. doi: 10.1159/000251193. Epub 2009 Dec 8.

PMID:
19996660
7.

[Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report].

Yoshinaga A, Kamata S.

Hinyokika Kiyo. 2015 May;61(5):201-5. Japanese.

8.

Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma.

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W.

Clin Oncol (R Coll Radiol). 2011 Jun;23(5):339-43. doi: 10.1016/j.clon.2010.11.006. Epub 2010 Dec 4.

PMID:
21134733
9.

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma.

Elfiky AA, Cho DC, McDermott DF, Rosenberg JE, Fortner B, Antràs L, Chen K, Sheng Duh M, Jayawant SS, Oh WK, Atkins MB, Choueiri TK.

Urol Oncol. 2011 Nov-Dec;29(6):756-63. doi: 10.1016/j.urolonc.2010.01.008. Epub 2010 May 6.

PMID:
20451414
10.

[A case of interstitial lung disease due to sunitinib].

Sekiguchi Z, Takizawa A, Takeshima T, Tsuchiya F, Iwasaki A, Matsuyama S, Hirooka N.

Hinyokika Kiyo. 2012 Sep;58(9):481-5. Japanese.

11.

An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib.

Pwint TP, Macaulay V, Roberts IS, Sullivan M, Protheroe A.

Urol Oncol. 2011 Nov-Dec;29(6):821-4. doi: 10.1016/j.urolonc.2009.10.007. Epub 2009 Dec 4.

PMID:
19962921
12.

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S, Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring P, Nieto A, Yuan J, Bukowski R.

Lancet Oncol. 2009 Aug;10(8):757-63. doi: 10.1016/S1470-2045(09)70162-7. Epub 2009 Jul 15.

PMID:
19615940
13.

[Cardiac tamponade due to pericardial metastasis from renal cell carcinoma : a case report].

Ueda N, Arai Y, Matsuzaki K, Yamamoto Y, Takeda K, Nakata W, Nakayama M, Kakimoto K, Nishimura K.

Hinyokika Kiyo. 2012 Sep;58(9):491-4. Japanese.

14.

Outcome of patients with renal cell carcinoma metastatic to the brain treated with sunitinib without local therapy.

Lim ZD, Mahajan A, Weinberg J, Tannir NM.

Am J Clin Oncol. 2013 Jun;36(3):258-60. doi: 10.1097/COC.0b013e3182467b9a.

PMID:
22441343
15.

Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience.

Ansari J, Fatima A, Fernando K, Collins S, James ND, Porfiri E.

Oncol Rep. 2010 Aug;24(2):507-10.

PMID:
20596640
16.

Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.

Salem ME, Shah SN, Elson P, Garcia JA, Wood LS, Medsinge A, Campbell S, Dreicer R, Rini BI.

Clin Genitourin Cancer. 2014 Apr;12(2):117-23. doi: 10.1016/j.clgc.2013.08.001. Epub 2013 Oct 12.

PMID:
24126239
17.

[Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].

Okazaki S, Hori J, Watanabe M, Hashizume K, Kobayashi S, Azumi M, Kita M, Iwata T, Matsumoto S, Kakizaki H.

Hinyokika Kiyo. 2016 Feb;62(2):73-6. Japanese.

18.

Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma.

Heng DY, Rini BI, Garcia J, Wood L, Bukowski RM.

Clin Genitourin Cancer. 2007 Dec;5(7):446-51. doi: 10.3816/CGC.2007.n.033.

PMID:
18272027
19.

[A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].

Ohtake S, Namura K, Fujikawa A, Sawada T, Ohta J, Moriyama M, Hayashi H.

Hinyokika Kiyo. 2014 Feb;60(2):75-8. Japanese.

20.

Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma.

Molina AM, Feldman DR, Ginsberg MS, Kroog G, Tickoo SK, Jia X, Georges M, Patil S, Baum MS, Reuter VE, Motzer RJ.

Invest New Drugs. 2012 Feb;30(1):335-40. doi: 10.1007/s10637-010-9491-6. Epub 2010 Aug 14.

Supplemental Content

Support Center